Clinical Trials
45 trialsPeople's Hospital of Xinjiang Uygur Autonomous Region
People's Hospital of Xinjiang Uygur Autonomous Region
MYELAXAT
University Hospital, Grenoble
CARAVAGGIO
Fadoi Foundation, Italy
Evaluating the Risk of Postoperative Venous Thromboembolism in Cervical Cancer Patients
Chongqing University Cancer Hospital
AIRPORT-MPN
Ottawa Hospital Research Institute
CONTEST
University of Aarhus
ROSIE
Radboud University Medical Center
Risk Factors of Venous Thromboembolism After Colorectal Cancer Surgery
Pirogov Russian National Research Medical University
Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO
Centre Hospitalier Universitaire de Saint Etienne
CANVAS
Alliance Foundation Trials, LLC.
THRIMM
University Medical Center Groningen
Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy
Duke University
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
McMaster University
Tumor-educated Platelets in Venous Thromboembolism
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection
McMaster University
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Academic and Community Cancer Research United
HEMOBREAST
University Hospital, Geneva
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
University of Colorado, Denver
VENETIA
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Venous Thromboembolism in Advanced Gastric Cancer Patients
Asan Medical Center
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Dana-Farber Cancer Institute
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
Huazhong University of Science and Technology
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
Case Comprehensive Cancer Center
AVERT
Ottawa Hospital Research Institute
Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery
McMaster University
CASTA-DIVA
Assistance Publique - Hôpitaux de Paris
DISOLVE
University of Vermont
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
Gruppo Italiano Malattie EMatologiche dell'Adulto
ACT
Thomas Jefferson University
A Comparative Study of Prophylactic Anticoagulation in Meningioma Surgery
St. Olavs Hospital
REMARK
Ottawa Hospital Research Institute
Time of Treatment With LMWH in Cancer Patients With Thromboembolic Disease
Delos Clinical
The Roles of Tissue Factor in Malignant Gliomas
Ontario Clinical Oncology Group (OCOG)
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
SOME
Ottawa Hospital Research Institute
Long-term Active Surveillance Study for Oral Contraceptives (LASS)
Center for Epidemiology and Health Research, Germany
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery
Shanghai Zhongshan Hospital
Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer
University of Alabama at Birmingham
Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients
Duke University
GIVTE
University of Aarhus
Incidence of Venous Thromboembolism Following Surgery in Patients With Gastric Cancer
Seoul National University Bundang Hospital
Epidemiology of Venous Thromboembolism
Brigham and Women's Hospital
Multi-Center Human Alert Trial to Prevent DVT and PE
Brigham and Women's Hospital
Screening for Occult Malignancy in Idiopathic Venous Thromboembolism
University of Padova
Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients
Ontario Clinical Oncology Group (OCOG)